Buning; Christian

Patent Applications and Registrations

Patent applications and USPTO patent grants for Buning; Christian.The latest application filed is for "azetidine compounds as grp119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders".

Company Profile

1.30.35

Buning; Christian - Frankfurt am Main DE
Buning; Christian - Bonn DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Azetidine compounds as GPR119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders Grant 10,392,366 - Schwink , et al. A	2019-08-27
Azetidine Compounds As Grp119 Modulators For The Treatment Of Diabetes, Obesity, Dyslipidemia And Related Disorders App 20180237419 - Schwink; Lothar ; et al.	2018-08-23
Isoindolinone compounds as GPR119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders Grant 9,908,868 - Schwink , et al. March 6, 2	2018-03-06
Substituted indanone compounds as GPR119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders Grant 9,896,434 - Schwink , et al. February 20, 2	2018-02-20
Substituted fused heterocycles as GPR119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders Grant 9,758,520 - Schwink , et al. September 12, 2	2017-09-12
3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals Grant 9,751,858 - Ruf , et al. September 5, 2	2017-09-05
Substituted Indanone Compounds As Gpr119 Modulators For The Treatment Of Diabetes, Obesity, Dyslipidemia And Related Disorders App 20170029405 - SCHWINK; Lothar ; et al.	2017-02-02
Substituted Fused Heterocycles As Gpr119 Modulators For The Treatment Of Diabetes, Obesity, Dyslipidemia And Related Disorders App 20170022198 - SCHWINK; Lothar ; et al.	2017-01-26
Isoindolinone Compounds As Gpr119 Modulators For The Treatment Of Diabetes, Obesity, Dyslipidemia And Related Disorders App 20170022182 - SCHWINK; Lothar ; et al.	2017-01-26
3-heteroaroylamino-propionic Acid Derivatives And Their Use As Pharmaceuticals App 20160237060 - RUF; Sven ; et al.	2016-08-18
3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals Grant 9,353,068 - Ruf , et al. May 31, 2	2016-05-31
Biaryl-propionic acid derivatives and their use as pharmaceuticals Grant 9,199,947 - Ruf , et al. December 1, 2	2015-12-01
Substituted 3-thiazoloamino-propionic acid derivatives and their use as pharmaceuticals Grant 9,174,952 - Ruf , et al. November 3, 2	2015-11-03
Biaryl-propionic acid derivatives and their use as pharmaceuticals Grant 9,150,526 - Ruf , et al. October 6, 2	2015-10-06
Substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals Grant 9,120,783 - Ruf , et al. September 1, 2	2015-09-01
Substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals Grant 9,029,559 - Ruf , et al. May 12, 2	2015-05-12
Amino-substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals Grant 8,962,671 - Ruf , et al. February 24, 2	2015-02-24
Biaryl-propionic acid derivatives and their use as pharmaceuticals App 20140296239 - Ruf; Sven ; et al.	2014-10-02
Biaryl-Propionic Acid Derivatives and their Use as Pharmaceuticals App 20140296296 - Ruf; Sven ; et al.	2014-10-02
Substituted 3-heteroaroylamino-propionic Acid Derivatives And Their Use As Pharmaceuticals App 20140194445 - Ruf; Sven ; et al.	2014-07-10
Substituted 3-heteroaroylamino-propionic Acid Derivatives And Their Use As Pharmaceuticals App 20140135328 - Ruf; Sven ; et al.	2014-05-15
Oxygen-substituted 3-heteroaroylamino-propionic Acid Derivatives And Their Use As Pharmaceuticals App 20140128616 - RUF; Sven ; et al.	2014-05-08
Substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals Grant 8,669,370 - Ruf , et al. March 11, 2	2014-03-11
Oxygen-substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals Grant 8,664,257 - Ruf , et al. March 4, 2	2014-03-04
Use Of Telaprevir And Related Compounds In Atherosclerosis, Heart Failure, Renal Diseases, Liver Diseases Or Inflammatory Diseases App 20130123276 - Ruf; Sven ; et al.	2013-05-16
Use Of Boceprevir And Related Compounds In Atherosclerosis, Heart Failure, Renal Diseases, Liver Diseases Or Inflammatory Diseases App 20130123325 - Ruf; Sven ; et al.	2013-05-16
3-heteroaroylamino-propionic Acid Derivatives And Their Use As Pharmaceuticals App 20130053416 - RUF; Sven ; et al.	2013-02-28
Substituted 3-thiazoloamino-propionic Acid Derivatives And Their Use As Pharmaceuticals App 20130053402 - RUF; Sven ; et al.	2013-02-28
Oxygen-substituted 3-heteroaroylamino-propionic Acid Derivatives And Their Use As Pharmaceuticals App 20130046004 - Ruf; Sven ; et al.	2013-02-21
Substituted 3-heteroaroylamino-propionic Acid Derivatives And Their Use As Pharmaceuticals App 20120252809 - RUF; Sven ; et al.	2012-10-04
Amino-substituted 3-heteroaroylamino-propionic Acid Derivatives And Their Use As Pharmaceuticals App 20120232112 - RUF; Sven ; et al.	2012-09-13
Substituted 8-aminoalkylthioxanthines, and their use as inhibitors of dipeptidyl peptidase IV Grant 8,236,810 - Schoenafinger , et al. August 7, 2	2012-08-07
Amide-substituted 8-N-benzimidazoles, method for the production thereof, and use of the same as medicaments Grant 8,163,774 - DeFossa , et al. April 24, 2	2012-04-24
Aminocarbonyl-substituted 8-N-benzimidazoles, methods for their preparation and their use in pharmaceutical compositions Grant 8,138,207 - DeFossa , et al. March 20, 2	2012-03-20
Amino-substituted 8-N-benzimidazoles and methods for their use in blood sugar disorders Grant 8,003,668 - Defossa , et al. August 23, 2	2011-08-23
Substituted, bicyclic 8-pyrrolidinoxanthines, and methods for their use as inhibitors of dipeptidyl peptidase Grant 7,888,343 - Schoenafinger , et al. February 15, 2	2011-02-15
Substituted 8-aminoalkoxy-xanthine compounds and compositions useful in the treatment of hyperlipidemia and diabetes Grant 7,879,864 - Schoenafinger , et al. February 1, 2	2011-02-01
Substituted bicyclic 8-pyrrolidinoxanthines, methods for their production, pharmaceutical formulations and their use Grant 7,838,528 - Schoenafinger , et al. November 23, 2	2010-11-23
Substituted 2-aminoalkylthiobenzimidazole compounds, pharmaceutical compositions thereof and methods for their use Grant 7,795,445 - Defossa , et al. September 14, 2	2010-09-14
Substituted, bicyclic 8-pyrrolidinobenzimidazoles, methods for their production and their use as medicaments Grant 7,569,700 - Defossa , et al. August 4, 2	2009-08-04
Amide-substituted 8 N Benzimidazoles, Method For The Production Thereof, And Use Of The Same As Medicaments App 20080090868 - DEFOSSA; Elisabeth ; et al.	2008-04-17
Substituted, Bicyclic 8-pyrrolidinobenzimidazoles, Methods For Their Production And Their Use As Medicaments App 20080090890 - DEFOSSA; Elisabeth ; et al.	2008-04-17
Aminocarbonyl-substituted 8-n-benzimidazoles, Methods For Their Preparation And Their Use In Pharmaceutical Compositions App 20080090869 - DEFOSSA; Elisabeth ; et al.	2008-04-17
Amino-substituted 8-n-benzimidazoles And Methods For Their Use In Blood Sugar Disorders App 20080090870 - DEFOSSA; Elisabeth ; et al.	2008-04-17
Substituted 2-aminoalkylthiobenzimidazole Compounds, Pharmaceutical Compositions Thereof And Methods For Their Use App 20080090889 - DEFOSSA; Elisabeth ; et al.	2008-04-17
Substituted 8-aminoalkoxy-xanthine Compounds And Compositions Useful In The Treatment Of Hyperlipidemia And Diabetes App 20070299090 - Schoenafinger; Karl ; et al.	2007-12-27
Substituted 8-aminoalkylthioxanthines, And Their Use As Inhibitors Of Dipeptidyl Peptidase Iv App 20070265284 - Schoenafinger; Karl ; et al.	2007-11-15
Substituted, Bicyclic 8-pyrrolidinoxanthines, And Methods For Their Use As Inhibitors Of Dipeptidyl Peptidase App 20070197563 - SCHOENAFINGER; Karl ; et al.	2007-08-23
Substituted Bicyclic 8-pyrr0lidinoxanthines, Methods For Their Production, Pharmaceutical Formulations And Their Use App 20070167468 - SCHOENAFINGER; Karl ; et al.	2007-07-19
Cyanopyrrolidides, process for their preparation and their use as medicaments Grant 7,094,800 - Schoenafinger , et al. August 22, 2	2006-08-22
Bicyclic cyanoheterocycles, process for their preparation and their use as medicaments Grant 7,008,957 - Wagner , et al. March 7, 2	2006-03-07
Novel bicyclic cyanoheterocycles, process for their preparation and their use as medicaments App 20050059716 - Wagner, Holger ; et al.	2005-03-17
Novel cyanopyrrolidides, process for their preparation and their use as medicaments App 20050059724 - Schoenafinger, Karl ; et al.	2005-03-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.